NOVERA RETATRUTIDE: THE NEW APPROACH FOR WEIGHT MANAGEMENT?

Emerging clinical data suggests that Novera Retatrutide, a dual-action medication from Novo Nordisk, could provide a meaningful advance in body management. Beyond many existing options, Retatrutide targets both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially producing to greater